Large-vessel vasculitis: Unresolved issues

Arthritis and Rheumatism

Volumn 48, Issue 9, 2003, Pages 2406-2414

  Hoffman, Gary S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ELASTIN;

ANIMAL MODEL; AORTA ANEURYSM; AORTA ROOT; AORTITIS; ARTERY DIAMETER; ARTERY WALL; DESCENDING AORTA; HUMAN; IMMUNE RESPONSE; INFLAMMATORY DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE; VASCULITIS;

ANIMALS; AORTIC ANEURYSM; AORTITIS; ARTERIOSCLEROSIS; HUMANS; TEMPORAL ARTERITIS;

EID: 0141676485     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11243     Document Type: Review

References (41)

1. Osler W. In: Modern medicine, its theory and practice. Philadelphia: Lea and Febiger; 1908.
2. Ibn Isa A. Memorandum book of a tenth-century oculist for the use of modern ophthalmologists. CA Wood, translator. Chicago: Northwestern University Press; 1936. p. 225.
3. Horton BT, Magath TB, Brown GE. An undescribed form of arteritis of temporal vessels. Mayo Clin Proc 1932;7:700-1.
4. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med 1994;120:919-29.
5. Rojo-Leyva F, Ratliff NB, Cosgrove DM III, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum 2000;43:901-7.
6. Svensjo S, Bengtsson H, Bergqvist D. Thoracic and thoracoabdominal aortic aneurysm and dissection: investigation based on autopsy. Br J Surg 1996;83:68-71.
7. Ostberg G. An arteritis with special reference to polymyalgia rheumatica. Acta Pathol Microbiol Scand [A] 1973;237 Suppl 237:1-59.
8. Bickerstaff LK, Pairolero PC, Hollier LH, Melton J, Van Peenen HJ, Cherry KJ, et al. Thoracic aortic aneurysms: a population-based study. Surgery 1982;92:1103-8.
9. Pomerance A, Yacoub MH, Gula G. The surgical pathology of thoracic aortic aneurysms. Histopathology 1997;1:257-76.
10. Okuyama K, Yaginuma G, Takahashi T, Sasaki H, Mori S. The development of vasa vasorum of the human aorta in various conditions: a morphometric study. Arch Pathol Lab Med 1988;112:721-5.
11. Schutte HE. Changes in the vasa vasorum of the atherosclerotic aortic wall. Angiologica 1968;5:210-22.
12. Fischer GM, Swain ML, Cherian K. Increased collagen and elastin synthesis in experimental atherosclerosis in the rabbit: variation in synthesis among major vessels. Atherosclerosis 1980;35:11-20.
13. Sokolis DP, Boudoulas H, Kavantzas NG, Kostomitsopulous N, Agapitos EV, Karayannacos PE. A morphometric study of the structural characteristics of the aorta in pigs using an image analysis method. Anat Histol Embryol 2002;31:21-30.
14. Karnik SK, Brooke BS, Bayes-Genis A, Sorensen L, Wythe JD, Schwartz RS, et al. A critical role for elastin signaling in vascular morphogenesis and disease. Development 2003;130:411-23.
15. Schlatmann T, Becker A. Pathogenesis of dissecting aneurysm of aorta: comparative histopathologic study of significance of medial changes. Am J Cardiol 1977;39:21-6.
16. Haimovici H, Maier N. Role of arterial tissue susceptibility in experimental canine atherosclerosis. J Atherosclerosis Res 1966;6:62-74.
17. Oz MC, Brener BJ, Buda JA, Todd G, Brenner RW, Goldenkranz RJ, et al. A ten-year experience with bacterial aortitis. J Vasc Surg 1989;10:439-49.
18. Heggtveit HA. Syphilitic aortitis: a clinicopathologic autopsy study of 100 cases, 1950-1960. Circulation 1964;29:346-55.
19. Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 1994;48:585-617.
20. Brown EL, Wooten RM, Johnson BJ, Iozzo RV, Smith A, Dolan MC, et al. Resistance to Lyme disease in decorin-deficient mice. J Clin Invest 2001;107:845-52.
21. Misiani R. Virus-associated vasculitides: pathogenesis. In: Hoffman GS, Weyand CM, editors. Inflammatory diseases of blood vessels. New York: Marcel Dekker; 2002. p. 553-63.
22. Vassiloppoulos D, Calabrese LH. Virus-associated vasculitides: clinical aspects. In: Hoffman GS, Weyand CM, editors. Inflammatory diseases of blood vessels. New York: Marcel Dekker; 2002. p. 565-97.
23. Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL. Association between polyarteritis and Australia antigen. Lancet 1970;2:1149-53.
24. Trepo C, Thivolet J. Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang 1970;19:410-1.
25. Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, Waggoner JG, et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med 1987;316:965-70.
26. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991;32:294-8.
27. Feldman M. Hepatitis B virus. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 6th ed. Philadelphia: Saunders; 1998. p. 1129-44.
28. Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997;40:2007-15.
29. Kikuta H, Sakiyama Y, Matsumoto S, Hamada I, Yazaki M, Iwaki T, et al. Detection of Epstein-Barr virus DNA in cardiac and aortic tissues from chronic, active Epstein-Barr virus infection associated with Kawasaki disease-like coronary artery aneurysms. J Pediatr 1993;123:90-2.
30. Murakami K, Ohsawa M, Hu S-X, Kanno H, Aozasa K, Nose M. Large-vessel arteritis associated with chronic active Epstein-Barr virus infection. Arthritis Rheum 1998;41:369-73.
31. Henson JB, Gorham JR. Animal model of human disease. Am J Pathol 1973;71:345-8.
32. Henson JB, Crawford TB. The pathogenesis of viral-induced arterial disease: Aleutian disease and equine viral arteritis. Adv Cardiol 1974;13:183-91.
33. Hadlow WJ, Race RE, Kennedy RC. Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun 1983;41:1016-23.
34. Weck KE, Dal Canto AJ, Gould JD, O'Guin AK, Roth KA, Saffitz JE, et al. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat Med 1997;3:1346-53.
35. Dal Canto AJ, Swanson PE, O'Guin AK, Speck SH, Virgin HW. IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. J Clin Invest 2001;107:R15-22.
36. Dal Canto AJ, Virgin HW, Speck SH. Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage. J Virol 2000;74:11304-10.
37. Presti RM, Pollock JL, Dal Canto AJ, O'Guin AK, Virgin HW. Interferon-alpha regulates acute and latent murine cytomegalovirus infection and chronic disease of great vessels. J Exp Med 1998;188:577-88.
38. Nicklin MJH, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 2000;191:303-11.
39. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000;191:313-20.
40. Weyand CM, Goronzy JJ. Multisystem interactions in the pathogenesis of vasculitis. Curr Opin Rheumatol 1997;9:3-11.
41. Brack A, Geisler A, Martinez-Taboada VM, Younge BR, Goronzy JJ, Weyand CM. Giant cell arteritis is a T cell-dependent disease. Mol Med 1997;3:530-43.